Back to CVE records
Medium 5.3Published Sep 10, 2026

CVE-2026-88896EspoCRM before 10.0.4 SSRF via IPv6 Transition Address Bypass

Updated under an hour ago ()

Does this affect you?

It affects espocrm. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

EspoCRM before 10.0.4 is vulnerable to server-side request forgery. HostCheck::ipAddressIsNotInternal(), which validates outbound URLs to block requests to internal/private IP addresses, strips ::ffff: (IPv4-mapped IPv6) prefixes but does not recognize IPv6 transition addresses that embed private IPv4 addresses: NAT64 (64:ff9b::), 6to4 (2002::), and Teredo (2001:0000::). An attacker who controls a domain with AAAA records pointing to such transition addresses can bypass both the internal-host validation and the CURLOPT_RESOLVE IP-pinning check, causing EspoCRM to issue outbound requests to internal network services. Affected paths include POST /Attachment/fromImageUrl, reachable by any authenticated user with attachment access, and outbound webhook delivery, which requires an admin or API user.

CVSS
5.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
Weakness (CWE)
CWE-918
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulnCheck
NVD analysis
Deferred
Record last updated
Sep 15, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
espocrm espocrm
espocrm:espocrm (from the name)
before 10.0.4; 10.0.4 not affected
CNA record

References

  • vendor-advisory
  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.